WKN: | A0JLZ0 |
ISIN: | FR0010313833 |
Land: | Frankreich |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Chemie |
Weshalb die Arkema-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 22. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2009 | 10,99 | 24,71 | 124,84% |
2 | 2010 | 24,71 | 50,65 | 104,98% |
3 | 2012 | 52,02 | 76,93 | 47,89% |
4 | 2016 | 64,99 | 92,19 | 41,85% |
5 | 2021 | 95,10 | 124,15 | 30,55% |
6 | 2019 | 73,82 | 95,08 | 28,80% |
7 | 2023 | 84,78 | 102,25 | 20,61% |
8 | 2015 | 54,81 | 64,99 | 18,57% |
9 | 2007 | 37,42 | 42,35 | 13,17% |
10 | 2017 | 92,19 | 102,11 | 10,76% |
11 | 2013 | 76,93 | 80,61 | 4,78% |
12 | 2011 | 50,65 | 52,02 | 2,70% |
13 | 2020 | 95,08 | 95,10 | 0,02% |
14 | 2025 | 71,45 | 56,40 | -21,06% |
15 | 2018 | 102,11 | 73,82 | -27,71% |
16 | 2024 | 102,25 | 71,45 | -30,12% |
17 | 2022 | 124,15 | 84,78 | -31,71% |
18 | 2014 | 80,61 | 54,81 | -32,01% |
19 | 2008 | 42,35 | 10,99 | -74,05% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 42,35 | 10,99 | -74,05% |
2 | 2014 | 80,61 | 54,81 | -32,01% |
3 | 2022 | 124,15 | 84,78 | -31,71% |
4 | 2024 | 102,25 | 71,45 | -30,12% |
5 | 2018 | 102,11 | 73,82 | -27,71% |
6 | 2025 | 71,45 | 56,40 | -21,06% |
7 | 2020 | 95,08 | 95,10 | 0,02% |
8 | 2011 | 50,65 | 52,02 | 2,70% |
9 | 2013 | 76,93 | 80,61 | 4,78% |
10 | 2017 | 92,19 | 102,11 | 10,76% |
11 | 2007 | 37,42 | 42,35 | 13,17% |
12 | 2015 | 54,81 | 64,99 | 18,57% |
13 | 2023 | 84,78 | 102,25 | 20,61% |
14 | 2019 | 73,82 | 95,08 | 28,80% |
15 | 2021 | 95,10 | 124,15 | 30,55% |
16 | 2016 | 64,99 | 92,19 | 41,85% |
17 | 2012 | 52,02 | 76,93 | 47,89% |
18 | 2010 | 24,71 | 50,65 | 104,98% |
19 | 2009 | 10,99 | 24,71 | 124,84% |